Purity >97%, by SDS-PAGE under reducing conditions and visualized by silver stain. MW (theoretical): 7.8 kDa. The Recombinant Human CCL18/PARC Protein from R&D Systems is derived from E. coli. The Recombinant Human CCL18/PARC Protein has been validated for the following applications: Bioactivity.
Size
50 ug
Concentration
n/a
Applications
Bioactivity
Other Names
Alternative macrophage activation-associated CC chemokine 1, AMAC-1, AMAC1CC chemokine ligand 18, AMAC-1Small-inducible cytokine A18, chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated), CKb7, DC-CK1, DC-CK1CC chemokine PARC, DCCK1Macrophage inflammatory protein 4, Dendritic cell chemokine 1, MIP4, MIP-4, MIP-4C-C motif chemokine 18, PARC, PARCPulmonary and activation-regulated chemokine, SCYA18chemokine (C-C), dendritic, small inducible cytokine A18, small inducible cytokine subfamily A (Cys-Cys), member 18, pulmonary andactivation-regulated